Dr. Corinna Clio Zygourakis, MD

Dr. Zygourakis practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Zygourakis' NPI, 1235456476, was assigned on April 28, 2010. Dr. Zygourakis graduated from Harvard Medical School in 2011. Dr. Zygourakis holds California license A124015.

Dr. Zygourakis' primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Zygourakis' primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Zygourakis to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Zygourakis' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zygourakis practices, 4 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Zygourakis' primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Zygourakis is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Zygourakis' licenses on file in 2 states: California and Maryland.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Zygourakis treats.

CMS data shows 180 Medicare services from Dr. Zygourakis across 7 procedure codes in 2024, for 150 Medicare patients. Medicare paid $27,080 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 150 Medicare patients who saw Dr. Zygourakis in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have arthritis, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zygourakis' median patient age at 61, with 44% women.

In 2024, Dr. Zygourakis wrote 33 Medicare Part D claims for 24 patients. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $460 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Zygourakis for performance year 2024, reported as part of a group. Dr. Zygourakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zygourakis as offering telehealth. CMS counts 102 procedures of spinal fusion by Dr. Zygourakis, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 128 papers to Dr. Zygourakis, published from 2011 to 2025. 2024 was the busiest year, with 19. The most frequent topics are Spinal Fusion, Neurosurgical Procedures and Lumbar Vertebrae. Dr. Zygourakis has published most often in World Neurosurg. Dr. Zygourakis' most frequent co-authors are John Kevin Ratliff, MD, Atman Mukesh Desai, MD and Nicholas Theodore, MD.

CMS Open Payments shows 155 general payments to Dr. Zygourakis from 18 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 59% of the total. Stryker Corporation paid the most, $19,893. It also lists 2 research payments totaling $264 from 2024 to 2025.

Dr. Zygourakis graduated from Harvard Medical School in 2011.

Dr. Zygourakis is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.